Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study

MLA

Poulsen MH, et al. “Does Therapy of the Primary Tumor Matter in Oligometastatic Prostate Cancer? A Prospective 10-Year Follow-up Study.” Research and Reports in Urology, vol. ume 11, July 2019, pp. 215–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4b975c43c37c436195b9c23ba52765d2&authtype=sso&custid=ns315887.

APA

Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF, & Lund L. (2019). Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study. Research and Reports in Urology, ume 11, 215–221.

Chicago

Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF, and Lund L. 2019. “Does Therapy of the Primary Tumor Matter in Oligometastatic Prostate Cancer? A Prospective 10-Year Follow-up Study.” Research and Reports in Urology ume 11 (July): 215–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4b975c43c37c436195b9c23ba52765d2&authtype=sso&custid=ns315887.